Inhibition of pseudointimal hyperplasia in swine TIPS models: The efficacy of local delivery of paclitaxel using a perforated balloon catheter

Sang Woo Park, S. H. Lee, Chul Hwan Kim, G. S. Jeon, Suk-Joo Hong, J. G. Yi, H. J. Jeon

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of this study was to investigate the efficacy and feasibility of local delivery of paclitaxel to inhibit pseudointimal hyperplasia/intimal hyperplasia in swine transjugular intrahepatic portosystemic shunt (TIPS) models. TIPS were created in seven healthy domestic swine (15-20 kg). Before TIPS stent insertion, we performed a short-term infusion of paclitaxel (treatment group: n=4) and saline (control group: n=3) into the TIPS tract using a balloon catheter in which two 0.010 inch holes were created on opposite sides of the balloon. Paclitaxel or saline was given to all animals via the hepatic parenchymal and venous outflow tract. The animals were followed for up to two weeks and then killed. Gross and histological evaluations of the shunts were performed, and the maximum pseudointimal/intimal hyperplasia thicknesses were calculated for each animal. The average infusion time of paclitaxel or saline was 7.6 min (6-9 min). At gross and histological evaluation, considerable pseudointimal hyperplasia had formed in the control group and statistically significant differences were found upon microscopic evaluation in the maximum pseudointimal hyperplasia thickness between the control (2.41 mm, range 1.7-3.16 mm) and animals receiving paclitaxel (0.63 mm, range 0.42-0.98 mm, p<0.05). Local delivery of paclitaxel at the time of TIPS creation may have been effective in reducing pseudointimal/intimal hyperplasia in swine TIPS models.

Original languageEnglish
Pages (from-to)702-707
Number of pages6
JournalBritish Journal of Radiology
Volume80
Issue number957
DOIs
Publication statusPublished - 2007 Sep 1

Fingerprint

Transjugular Intrahepatic Portasystemic Shunt
Paclitaxel
Hyperplasia
Swine
Catheters
Tunica Intima
Control Groups
Stents
Liver

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Inhibition of pseudointimal hyperplasia in swine TIPS models : The efficacy of local delivery of paclitaxel using a perforated balloon catheter. / Park, Sang Woo; Lee, S. H.; Kim, Chul Hwan; Jeon, G. S.; Hong, Suk-Joo; Yi, J. G.; Jeon, H. J.

In: British Journal of Radiology, Vol. 80, No. 957, 01.09.2007, p. 702-707.

Research output: Contribution to journalArticle

@article{0b8fd9042e5e4aaebb51c4bbcb600218,
title = "Inhibition of pseudointimal hyperplasia in swine TIPS models: The efficacy of local delivery of paclitaxel using a perforated balloon catheter",
abstract = "The aim of this study was to investigate the efficacy and feasibility of local delivery of paclitaxel to inhibit pseudointimal hyperplasia/intimal hyperplasia in swine transjugular intrahepatic portosystemic shunt (TIPS) models. TIPS were created in seven healthy domestic swine (15-20 kg). Before TIPS stent insertion, we performed a short-term infusion of paclitaxel (treatment group: n=4) and saline (control group: n=3) into the TIPS tract using a balloon catheter in which two 0.010 inch holes were created on opposite sides of the balloon. Paclitaxel or saline was given to all animals via the hepatic parenchymal and venous outflow tract. The animals were followed for up to two weeks and then killed. Gross and histological evaluations of the shunts were performed, and the maximum pseudointimal/intimal hyperplasia thicknesses were calculated for each animal. The average infusion time of paclitaxel or saline was 7.6 min (6-9 min). At gross and histological evaluation, considerable pseudointimal hyperplasia had formed in the control group and statistically significant differences were found upon microscopic evaluation in the maximum pseudointimal hyperplasia thickness between the control (2.41 mm, range 1.7-3.16 mm) and animals receiving paclitaxel (0.63 mm, range 0.42-0.98 mm, p<0.05). Local delivery of paclitaxel at the time of TIPS creation may have been effective in reducing pseudointimal/intimal hyperplasia in swine TIPS models.",
author = "Park, {Sang Woo} and Lee, {S. H.} and Kim, {Chul Hwan} and Jeon, {G. S.} and Suk-Joo Hong and Yi, {J. G.} and Jeon, {H. J.}",
year = "2007",
month = "9",
day = "1",
doi = "10.1259/bjr/18259234",
language = "English",
volume = "80",
pages = "702--707",
journal = "The British journal of radiology.",
issn = "0007-1285",
publisher = "British Institute of Radiology",
number = "957",

}

TY - JOUR

T1 - Inhibition of pseudointimal hyperplasia in swine TIPS models

T2 - The efficacy of local delivery of paclitaxel using a perforated balloon catheter

AU - Park, Sang Woo

AU - Lee, S. H.

AU - Kim, Chul Hwan

AU - Jeon, G. S.

AU - Hong, Suk-Joo

AU - Yi, J. G.

AU - Jeon, H. J.

PY - 2007/9/1

Y1 - 2007/9/1

N2 - The aim of this study was to investigate the efficacy and feasibility of local delivery of paclitaxel to inhibit pseudointimal hyperplasia/intimal hyperplasia in swine transjugular intrahepatic portosystemic shunt (TIPS) models. TIPS were created in seven healthy domestic swine (15-20 kg). Before TIPS stent insertion, we performed a short-term infusion of paclitaxel (treatment group: n=4) and saline (control group: n=3) into the TIPS tract using a balloon catheter in which two 0.010 inch holes were created on opposite sides of the balloon. Paclitaxel or saline was given to all animals via the hepatic parenchymal and venous outflow tract. The animals were followed for up to two weeks and then killed. Gross and histological evaluations of the shunts were performed, and the maximum pseudointimal/intimal hyperplasia thicknesses were calculated for each animal. The average infusion time of paclitaxel or saline was 7.6 min (6-9 min). At gross and histological evaluation, considerable pseudointimal hyperplasia had formed in the control group and statistically significant differences were found upon microscopic evaluation in the maximum pseudointimal hyperplasia thickness between the control (2.41 mm, range 1.7-3.16 mm) and animals receiving paclitaxel (0.63 mm, range 0.42-0.98 mm, p<0.05). Local delivery of paclitaxel at the time of TIPS creation may have been effective in reducing pseudointimal/intimal hyperplasia in swine TIPS models.

AB - The aim of this study was to investigate the efficacy and feasibility of local delivery of paclitaxel to inhibit pseudointimal hyperplasia/intimal hyperplasia in swine transjugular intrahepatic portosystemic shunt (TIPS) models. TIPS were created in seven healthy domestic swine (15-20 kg). Before TIPS stent insertion, we performed a short-term infusion of paclitaxel (treatment group: n=4) and saline (control group: n=3) into the TIPS tract using a balloon catheter in which two 0.010 inch holes were created on opposite sides of the balloon. Paclitaxel or saline was given to all animals via the hepatic parenchymal and venous outflow tract. The animals were followed for up to two weeks and then killed. Gross and histological evaluations of the shunts were performed, and the maximum pseudointimal/intimal hyperplasia thicknesses were calculated for each animal. The average infusion time of paclitaxel or saline was 7.6 min (6-9 min). At gross and histological evaluation, considerable pseudointimal hyperplasia had formed in the control group and statistically significant differences were found upon microscopic evaluation in the maximum pseudointimal hyperplasia thickness between the control (2.41 mm, range 1.7-3.16 mm) and animals receiving paclitaxel (0.63 mm, range 0.42-0.98 mm, p<0.05). Local delivery of paclitaxel at the time of TIPS creation may have been effective in reducing pseudointimal/intimal hyperplasia in swine TIPS models.

UR - http://www.scopus.com/inward/record.url?scp=35548973536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548973536&partnerID=8YFLogxK

U2 - 10.1259/bjr/18259234

DO - 10.1259/bjr/18259234

M3 - Article

C2 - 17928498

AN - SCOPUS:35548973536

VL - 80

SP - 702

EP - 707

JO - The British journal of radiology.

JF - The British journal of radiology.

SN - 0007-1285

IS - 957

ER -